SEC Form 4 · accession 0000899243-15-003913

ZS Pharma, Inc. · ZSPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Other

Period of report

Aug 20, 2015

Accepted (ET)

Aug 24, 2015 · 6:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001459266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 20, 2015	M	20,000	$2.13	A	20,000	D
Common Stock	Aug 20, 2015	S	20,000	$50.03	D	0	D
Common Stock	Aug 21, 2015	M	50,000	$2.13	A	50,000	D
Common Stock^F1	Aug 21, 2015	S	50,000	$49.76	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Options^F2	$2.13	Aug 20, 2015	M	20,000	D	—	—	Common Stock	20,000	260,771	D
Employee Stock Options^F2	$2.13	Aug 21, 2015	M	50,000	D	—	—	Common Stock	50,000	210,771	D

F1Mr. Creech sold 50,000 shares of common stock at prices ranging from $49.50 per share to $50.01 per share.
F2Mr. Creech was granted options to purchase 280,771 shares of common stock at an exercise price of $2.13 per share on August 16, 2013, of which 25% of the shares subject to such option vested on August 12, 2014, the first anniversary of the vesting commencement date, with the remaining 75% of the options vesting monthly in substantially equal installments over the following 36 months, subject to Mr. Creech's continuing to provide services to the company through each vesting date. Mr. Creech exercised 20,000 of such options on August 20, 2015 and 50,000 of such options on August 21, 2015, all at the exercise price of $2.13 per share.

Mr. Creech no longer serves as the Chief Financial Officer of ZS Pharma, Inc., effective as of June 15, 2015.